AV
AVTR.US Avantor Inc
- Market cap
- USD 10.5B
- P/E
- 31.1x
- P/B
- 1.81x
- ROE
- 6.5%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is AVTR.US undervalued?
Graham numberAVTR.US trades 58.3% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Avantor Inc fundamental analysis
No fundamental analysis for Avantor Inc yet.
Avantor Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Avantor Inc
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chrom…
Full company profileAvantor Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Avantor Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 691M | 1.25B | 5.86B | 6.04B | 6.39B | 7.39B | 4.91B | 6.97B | 6.78B | 6.55B | 6.63B |
| Gross Profit | 320M | 433M | 1.82B | 1.92B | 2.08B | 2.50B | 2.60B | 2.36B | 2.28B | 2.14B | 2.10B |
| Operating Income | 9.90M | -210M | 414M | 552M | 707M | 972M | 1.13B | 696M | 1.08B | -246M | 502M |
| EBITDA | 70.0M | -160M | 815M | 880M | 765M | 1.35B | 1.53B | 1.10B | 1.48B | 139M | 914M |
| Net Income | -42.4M | -113M | -86.9M | 37.8M | 117M | 573M | 687M | 321M | 712M | -530M | 380M |
| EPS | -0.09 | -0.23 | -0.18 | 0.09 | 0.20 | 0.95 | 1.01 | 0.47 | 1.04 | -0.78 | 0.56 |
| Balance Sheet | |||||||||||
| Total Assets | 1.14B | 10.4B | 9.91B | 9.77B | 9.91B | 13.9B | 13.5B | 13.0B | 12.1B | 11.8B | 11.6B |
| Total Liabilities | 1.65B | 13.1B | 13.0B | 7.31B | 7.23B | 9.70B | 8.61B | 7.72B | 6.16B | 6.23B | 5.79B |
| Shareholders' Equity | -375M | -2.62B | -3.05B | 2.46B | 2.67B | 4.20B | 4.86B | 5.25B | 5.96B | 5.57B | 5.84B |
| Cash & Short-term Investments | 62.9M | 185M | 185M | 187M | 287M | 302M | 373M | 263M | 262M | 365M | 464M |
| Total Debt | 1.30B | 7.12B | 6.92B | 5.12B | 4.89B | 7.02B | 6.29B | 5.54B | 4.06B | 3.95B | 3.68B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 72.9M | -168M | 201M | 354M | 930M | 954M | 844M | 870M | 841M | 624M | 576M |
| Capital Expenditure | 29.9M | 25.2M | 37.7M | 51.6M | 61.6M | 111M | 133M | 146M | 149M | 129M | 147M |
| Free Cash Flow | 43.0M | -193M | 163M | 302M | 868M | 843M | 710M | 724M | 692M | 495M | 429M |
| Ratios | |||||||||||
| ROE | - | - | - | 1.5% | 4.4% | 13.6% | 14.1% | 6.1% | 11.9% | -9.5% | 6.5% |
| ROA | -3.7% | -1.1% | -0.9% | 0.4% | 1.2% | 4.1% | 5.1% | 2.5% | 5.9% | -4.5% | 3.3% |
| Net Profit Margin | -6.1% | -9.0% | -1.5% | 0.6% | 1.8% | 7.8% | 14.0% | 4.6% | 10.5% | -8.1% | 5.7% |
| Debt to Equity | - | - | - | 2.08x | 1.83x | 1.67x | 1.29x | 1.05x | 0.68x | 0.71x | 0.63x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Avantor Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | USD 18.3M | 0.03 | 5.7% |
| 2022 | USD 32.4M | 0.05 | 4.7% |
| 2021 | USD 64.6M | 0.11 | 11.3% |
| 2020 | USD 64.6M | 0.11 | 55.4% |
| 2019 | USD 31.3M | 0.08 | 82.8% |
| 2018 | USD 31.3M | 0.06 | - |
| 2017 | USD 1.70B | 3.43 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Avantor Inc
- Insiders 1.54%
- Institutions 98.47%
- Public & others 0.00%
- Shares outstanding 678M
- Free float 659M
Top funds holding AVTR.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Dodge & Cox Stock I | 74.9M | 11.05% | 0.00% | Sep 2026 |
| iShares Core S&P Mid-Cap ETF | 24.3M | 3.59% | +0.05% | Oct 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 21.5M | 3.17% | -1.23% | Sep 2026 |
| Vanguard Small Cap Index | 15.2M | 2.25% | -3.15% | Sep 2026 |
| Bridge Builder Large Cap Value | 12.5M | 1.85% | +1.33% | Oct 2026 |
| DFA U.S. Small Cap Value I | 10.2M | 1.50% | +46.08% | Sep 2026 |
| Vanguard MStar Small Cap Value Index | 9.90M | 1.46% | -0.74% | Sep 2026 |
| Dodge & Cox Global Stock I | 7.76M | 1.14% | 0.00% | Sep 2026 |
| Undiscovered Managers Behavioral Val L | 7.35M | 1.08% | -8.52% | Sep 2026 |
| Invesco Small Cap Value A | 7.32M | 1.08% | -28.36% | Sep 2026 |
| Touchstone Mid Cap Y | 6.95M | 1.03% | -27.00% | Sep 2026 |
| Dodge & Cox Balanced I | 6.32M | 0.93% | 0.00% | Sep 2026 |
| State Street® SPDR® S&P MIDCAP 400® ETF | 5.00M | 0.74% | +0.16% | Sep 2026 |
| AMG Yacktman I | 4.50M | 0.66% | 0.00% | Sep 2026 |
| Longleaf Partners | 4.41M | 0.65% | +42.91% | Jun 2026 |
| Dodge & Cox Worldwide Global Stk USD Acc | 3.93M | 0.58% | 0.00% | Sep 2026 |
| FPA Crescent | 3.92M | 0.58% | -19.47% | Sep 2026 |
| State Street SPDR Port S&P 400 Md CpETF | 3.68M | 0.54% | +0.05% | Oct 2026 |
| iShares S&P Mid-Cap 400 Value ETF | 3.45M | 0.51% | +0.50% | Oct 2026 |
| BlackRock Large Cap Focus Value Instl | 3.39M | 0.50% | -1.59% | Sep 2026 |
Top institutions holding AVTR.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Dodge & Cox | 120M | 17.71% | +0.31% | Jun 2026 |
| BlackRock Inc | 70.3M | 10.37% | +6.97% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 31.3M | 4.63% | +0.22% | Jun 2026 |
| Vanguard Capital Management, LLC | 30.8M | 4.55% | +0.64% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 24.8M | 3.65% | +21.29% | Sep 2026 |
| Greenhaven Associates Inc | 24.6M | 3.64% | +9.04% | Jun 2026 |
| State Street Corp | 21.6M | 3.18% | +4.11% | Jun 2026 |
| Engine Capital Management LP | 19.9M | 2.93% | +0.40% | Jun 2026 |
| Barrow Hanley Mewhinney & Strauss LLC | 19.7M | 2.91% | -11.73% | Jun 2026 |
| New Mountain Capital, L.L.C. | 14.0M | 2.07% | 0.00% | Jun 2026 |
| Amvescap Plc. | 13.9M | 2.05% | +71.98% | Jun 2026 |
| Geode Capital Management, LLC | 13.2M | 1.95% | +2.24% | Jun 2026 |
| Marshall Wace Asset Management Ltd | 13.1M | 1.94% | +281.93% | Jun 2026 |
| AQR Capital Management LLC | 11.6M | 1.72% | +138.90% | Jun 2026 |
| Bank of America Corp | 11.0M | 1.62% | +55.49% | Jun 2026 |
| Earnest Partners LLC | 10.7M | 1.59% | +78.41% | Jun 2026 |
| London Company of Virginia | 10.5M | 1.55% | -3.38% | Jun 2026 |
| Fuller & Thaler Asset Management Inc | 10.3M | 1.51% | -3.53% | Jun 2026 |
| D. E. Shaw & Co LP | 9.57M | 1.41% | -26.99% | Jun 2026 |
| First Pacific Advisors, LP | 8.19M | 1.21% | +1.26% | Jun 2026 |
Avantor Inc company profile
- Company name
- Avantor Inc
- Ticker
- AVTR.US
- Exchange
- USA Stocks
- Listed since
- May 17, 2019
- Sector
- Healthcare
- Industry
- Life Sciences Tools & Services
- Employees
- 13,500
- Fiscal year end
- December
- Address
- Radnor Corporate Center, Radnor, PA, United States, 19087
- Phone
- 610 386 1700
- Website
- avantorsciences.com
About Avantor Inc
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Avantor Inc management
10- Mr. Emmanuel LignerPresident, CEO & Director · born 1971
- Mr. Claudius O. SokenuExecutive VP, Corporate Secretary and Chief Legal & Compliance Officer · born 1968
- Mr. Corey D. WalkerPresident of Laboratory Solutions · born 1978
- Mr. Benoit GourdierExecutive Vice President of Bioscience Production · born 1967
- Mr. Todd W. Garner C.P.A.Executive VP & CFO · born 1969
- Ms. Mary BlennExecutive VP & COO
- Mr. Steven W. EckSenior VP, Corporate Controller & Chief Accounting Officer · born 1976
- Mr. Mikey SantiagoChief Information Officer
- Mr. Chris FidykVice President of Investor Relations
- Ms. Brittany HankamerExecutive VP & Chief Human Resources Officer · born 1971